COVID-19 News

September 18, 2020September 18, 2020

E-cigarette Use Linked to Bronchiectasis in 3 Cases, Report Suggests

Bronchiectasis News Today, COVID-19 News

Use of electronic cigarettes, or e-cigarettes, is strongly suspected to have led to bronchiectasis in three young patients, according to a recent report. The use of e-cigarettes has not yet ... Read more

September 18, 2020September 18, 2020

National MS Society Launches Survey to Assess Economic Impact of MS

COVID-19 News, Multiple Sclerosis News Today

The National Multiple Sclerosis Society, together with the Lewin Group, has launched a survey to assess the economic impact multiple sclerosis (MS) has on patients and their families. In the ... Read more

September 17, 2020September 17, 2020

FDA Grants Rare Pediatric Disease Status to AML Therapy OXi-4503

Acute Myeloid Leukemia News, COVID-19 News

The U.S. Food and Drug Administration (FDA) has granted its Rare Pediatric Disease designation to Mateon Therapeutics’ OXi-4503 (combretastatin A1-diphosphate, CA1P) for the treatment of children and teens with acute ... Read more

September 17, 2020September 17, 2020

Patients With Impaired Lung Function May Have Higher Risk of Severe COVID-19

COVID-19 News, Sarcoidosis News

People with sarcoidosis who have impaired lung function seem to be at greater risk for severe COVID-19 disease, a new study suggests. The study, “Moderate or Severe Impairment in Pulmonary Function ... Read more

September 17, 2020September 17, 2020

Gene Therapy VY-AADC Improves Motor Function in Parkinson’s Patients, Studies Show

COVID-19 News, Parkinson's News Today

One-time treatment with investigational gene therapy VY-AADC (NBIb-1817) showed sustained improvement in motor function in patients with Parkinson’s, results from the Phase 1 PD-1102 clinical trial show. These results were ... Read more

September 17, 2020September 17, 2020

GreenLight Wins $3.3M Grant to Pursue mRNA-based Gene Therapies

COVID-19 News, Sickle Cell Disease News

The Bill & Melinda Gates Foundation has awarded a $3.3 million grant to GreenLight Biosciences to develop gene therapies revolving around messenger RNA (mRNA) — the intermediate molecule between DNA ... Read more

September 16, 2020September 17, 2020

Theme for World Alzheimer’s Month Is ‘Let’s Talk About Dementia’

Alzheimer's News Today, COVID-19 News

Events are underway to mark World Alzheimer’s Month, observed every September to raise global awareness about the disease and challenge the stigma regarding dementia. September 21 has been designated World Alzheimer’s ... Read more

September 16, 2020September 16, 2020

Spark Resumes Enrollment Into SPK-3006 Clinical Studies for LOPD, Stopped for COVID-19

COVID-19 News, Pompe Disease News

Spark Therapeutics has resumed enrollment into two international clinical studies testing SPK-3006, the company’s investigational gene therapy for Pompe disease. Recruitment of adults with late-onset Pompe disease (LOPD) into both ... Read more

September 15, 2020September 15, 2020

Cymerus MSCs Seen to Ease IPF Symptoms in Mouse Model of Disease

COVID-19 News, Pulmonary Fibrosis News

Using Cymerus mesenchymal stem cells (MSCs) to treat idiopathic pulmonary fibrosis (IPF) resulted in dramatic reductions in IPF symptoms and significant improvements in lung functionality in an animal model of the ... Read more

September 14, 2020September 14, 2020

PFF Sharing Patient Stories, Photos to Mark PF Awareness Month

COVID-19 News, Pulmonary Fibrosis News

In recognition of September being Pulmonary Fibrosis Awareness Month, the Pulmonary Fibrosis Foundation (PFF) is working to raise awareness about the realities of this disease and how it affects people’s ... Read more

September 11, 2020September 11, 2020

First US-based Anavex 2-73 Trial Completed; Top-line Results Due by Year’s End

COVID-19 News, Rett Syndrome News

A Phase 2 clinical trial evaluating the safety and efficacy of Anavex Life Sciences‘ investigational therapy Anavex 2-73 (blarcamesine) in Rett syndrome has been completed, according to the company. Top-line ... Read more

September 11, 2020September 11, 2020

Study Describes New Compounds With Potential to Treat ALS

ALS News Today, COVID-19 News

Newly developed compounds derived from ebselen could be used to treat some types of amyotrophic lateral sclerosis (ALS), a recent study suggests. The study, “Novel Selenium-based compounds with therapeutic potential ... Read more

September 10, 2020September 10, 2020

New and Ongoing Trials Evaluating Kesimpta, Including as Switch Therapy

COVID-19 News, Multiple Sclerosis News Today

Upcoming and ongoing clinical trials aim to expand an understanding of Kesimpta (ofatumumab), the Novartis therapy recently approved by the U.S. Food and Drug Administration (FDA) to treat relapsing forms of multiple sclerosis (MS). Kesimpta ... Read more

September 10, 2020September 10, 2020

#MSVirtual2020 – New Safety, Efficacy Data on Mavenclad, Rebif and Evobrutinib on Way

COVID-19 News, Multiple Sclerosis News Today

EMD Serono will present new data from programs assessing the efficacy and safety of Mavenclad (cladribine) and Rebif (interferon beta-1a), as well as investigative evobrutinib in treating relapsing forms of multiple sclerosis (MS) ... Read more

September 9, 2020September 9, 2020

CAD Possible in COVID-19 Patients With Blood Clotting Problems, Case Report Finds

Cold Agglutinin News, COVID-19 News

Physicians should consider testing patients with COVID-19 and thrombosis for different forms of autoimmune hemolytic anemia (AIHA), including cold agglutinin disease (CAD), which may underlie their blood clotting issues, a ... Read more